BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Biotech catalysts in 2026-05

177 industry Phase 2/3 trial readout(s) and 39 FDA decision event(s). Readouts include completed (ACTUAL) and still-estimated primary completion dates in this month, any status.

← 2026-04 | 2026-06 →

FDA decision events

DateEventStatusCompanyDrugSource
2026-05-01FDA approvalapprovedRIGEL PHARMS RIGLVEPPANUApproved 2026-05-01: VEPPANU (NDA219835 ORIG1)
2026-05-01FDA approvalapprovedAPOTEXEVDIApproved 2026-05-01: EVDI (NDA220837 ORIG1)
2026-05-01FDA approvalapprovedINCYTE CORP INCYJAKAFIApproved 2026-05-01: JAKAFI XR (NDA217180 ORIG1)
2026-05-07FDA approvalapprovedACCORD BIOPHARMA INC.ENNUMOApproved 2026-05-07: ENNUMO (BLA761147 ORIG1)
2026-05-08FDA approvalapprovedARGENX BVVYVGARTApproved 2026-05-08: VYVGART (BLA761195 SUPPL16)
2026-05-08FDA approvalapprovedARGENX BVVYVGART HYTRULOApproved 2026-05-08: VYVGART HYTRULO (BLA761304 SUPPL18)
2026-05-08FDA approvalapprovedMERUS N.V.BIZENGRIApproved 2026-05-08: BIZENGRI (BLA761352 SUPPL10)
2026-05-08FDA approvalapprovedGENENTECH INCOCREVUSApproved 2026-05-08: OCREVUS (BLA761053 SUPPL38)
2026-05-12FDA approvalapprovedCUBIST PHARMS LLCZERBAXAApproved 2026-05-12: ZERBAXA (NDA206829 SUPPL23)
2026-05-13FDA approvalapprovedTAIHO ONCOLOGYINQOVIApproved 2026-05-13: INQOVI (NDA212576 SUPPL8)
2026-05-13FDA approvalapprovedBEONE MEDICINES USA ONCBEQALZIApproved 2026-05-13: BEQALZI (NDA220711 ORIG1)
2026-05-13FDA approvalapprovedASTRAZENECA AB AZNFASENRAApproved 2026-05-13: FASENRA (BLA761070 SUPPL23)
2026-05-13FDA approvalapprovedPARATEK PHARMSNUZYRAApproved 2026-05-13: NUZYRA (NDA209816 SUPPL18)
2026-05-13FDA approvalapprovedPARATEK PHARMSNUZYRAApproved 2026-05-13: NUZYRA (NDA209817 SUPPL18)
2026-05-14FDA approvalapprovedCHIESITRIMBOWApproved 2026-05-14: TRIMBOW (NDA219622 ORIG1)
2026-05-15Complete response lettercomplete responseOcuvex Therapeutics, Inc.brimonidine tartrate ophthalmic suspensionCRL 2026-05-15: Ocuvex Therapeutics, Inc. NDA 217363 (brimonidine tartrate ophthalmic suspension 0)
2026-05-15FDA approvalapprovedASTRAZENECA AB AZNBAXFENDYApproved 2026-05-15: BAXFENDY (NDA219878 ORIG1)
2026-05-15FDA approvalapprovedGENENTECH INCTECENTRIQ HYBREZAApproved 2026-05-15: TECENTRIQ HYBREZA (BLA761347 SUPPL8)
2026-05-15FDA approvalapprovedGENENTECH INCTECENTRIQApproved 2026-05-15: TECENTRIQ (BLA761034 SUPPL61)
2026-05-15FDA approvalapprovedACCORD BIOPHARMA INC.IMMGOLIS IMMGOLIS INTRIApproved 2026-05-15: IMMGOLIS; IMMGOLIS INTRI (BLA761452 ORIG1)
2026-05-15FDA approvalapprovedDAIICHI SANKYOENHERTUApproved 2026-05-15: ENHERTU (BLA761139 SUPPL43)
2026-05-15FDA approvalapprovedDAIICHI SANKYOENHERTUApproved 2026-05-15: ENHERTU (BLA761139 SUPPL41)
2026-05-18FDA approvalapprovedINCYTE CORP INCYZYNYZApproved 2026-05-18: ZYNYZ (BLA761334 SUPPL9)
2026-05-20FDA approvalapprovedABBVIE ABBVVENCLEXTAApproved 2026-05-20: VENCLEXTA (NDA208573 SUPPL32)
2026-05-21FDA approvalapprovedABBVIE ABBVLINZESSApproved 2026-05-21: LINZESS (NDA202811 SUPPL23)
2026-05-22FDA approvalapprovedGALDERMA LABS LPDIFFERIN EPIDUO DIFFERIN EPIDUO ACNEApproved 2026-05-22: DIFFERIN EPIDUO; DIFFERIN EPIDUO ACNE GEL (ADAPALENE AND BENZOYL PEROXIDE) (NDA220736 ORIG1)
2026-05-22FDA approvalapprovedDAIICHI SANKYO INCDATROWAYApproved 2026-05-22: DATROWAY (BLA761394 SUPPL3)
2026-05-22FDA approvalapprovedGILEAD SCIENCES INC GILDHEPCLUDEXApproved 2026-05-22: HEPCLUDEX (BLA761468 ORIG1)
2026-05-23FDA approvalapprovedACTELIONUPTRAVIApproved 2026-05-23: UPTRAVI (NDA207947 SUPPL14)
2026-05-27FDA approvalapprovedABBVIE INC ABBVDECNUPAZApproved 2026-05-27: DECNUPAZ (BLA761460 ORIG1)
2026-05-28FDA AdComheldAdCom 2026-05-28: Vaccines and Related Biological Products Advisory Committee
2026-05-28FDA approvalapprovedJANSSEN BIOTECHTREMFYAApproved 2026-05-28: TREMFYA (BLA761061 SUPPL34)
2026-05-28FDA approvalapprovedASTRAZENECA UK LTD AZNIMFINZIApproved 2026-05-28: IMFINZI (BLA761069 SUPPL53)
2026-05-29Complete response lettercomplete responseCingulate Therapeutics, LLC CINGdexmethylphenidate hydrochlorideCRL 2026-05-29: Cingulate Therapeutics, LLC NDA 220283 (dexmethylphenidate hydrochloride extended-release tablets)
2026-05-29FDA approvalapprovedSHIONOGIXOCOVAApproved 2026-05-29: XOCOVA (NDA220442 ORIG1)
2026-05-29FDA approvalapprovedHAISCOCYPSEDOApproved 2026-05-29: CYPSEDO (NDA220482 ORIG1)
2026-05-29FDA approvalapprovedWOCKHARDT BIO AGZAYNICHApproved 2026-05-29: ZAYNICH (NDA220787 ORIG1)
2026-05-29FDA approvalapprovedMANNKIND MNKDAFREZZAApproved 2026-05-29: AFREZZA (BLA022472 SUPPL29)
2026-05-29FDA approvalapprovedCYCLECAVHANZAApproved 2026-05-29: CAVHANZA (NDA217379 ORIG1)

Trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-05 est.P1/P2AbbVie ABBVNCT03933735 A Study of TNB-383B in Participants With Relapsed or Refractory Multiple MyelomaMultiple Myelomaactive not recruiting220
2026-05 est.P3GC Biopharma CorpNCT04565015 Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral ImmunodeficiencyPrimary Immune Deficiencyactive not recruiting24
2026-05 est.P3EMSNCT04594018 Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic AlopeciaAndrogenetic Alopeciarecruiting190
2026-05 est.P3EMSNCT04602754 Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.Dyslipidemia Associated With Type II Diabetes Mellitusrecruiting228
2026-05 est.P3EMSNCT05052879 Efficacy and Safety of Toronto Association in the Treatment of Erectile Dysfunction and Premature EjaculationErectile Dysfunction; Premature Ejaculationunknown232
2026-05 est.P3AkesoNCT05235516 A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical CancerLocally Advanced Cervical Carcinomaactive not recruiting636
2026-05 est.P1/P2Jiangsu HengRui Medicine Co., Ltd.NCT05277168 A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORSAdvanced Solid Tumorsrecruiting83
2026-05 est.P3PT Bio FarmaNCT05482295 Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III)Vaccine Reaction; Vaccine Adverse Reactionnot yet recruiting540
2026-05 est.P3UnicoCell Biomed CO. LTDNCT05526001 Efficacy and Safety of ELIXCYTE Intra-articular Injection in Subject With Knee OsteoarthritisKnee Osteoarthritisactive not recruiting165
2026-05 est.P2Beijing InnoCare Pharma Tech Co., Ltd.NCT05678270 A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic CholangiocarcinomaIntrahepatic Cholangiocarcinoma (ICC)recruiting70
2026-05 est.P1/P2SURGE Therapeutics SRGXFNCT05710848 A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder CancerNon-muscle-invasive Bladder Cancerrecruiting75
2026-05 est.P1/P2Iterion TherapeuticsNCT05797805 A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular CarcinomaAdvanced Hepatocellular Carcinomarecruiting178
2026-05 est.P3EMSNCT05886088 Efficacy and Safety of LID104 in the Treatment of Type II Diabetes MellitusType 2 Diabetes Mellitusnot yet recruiting597
2026-05 est.P3Jiangsu HengRui Medicine Co., Ltd.NCT06122389 SHR2554 Clinical Study of Chidamide in the Treatment of T-cell LymphomaRelapsed/Refractory PTCLT With at Least One Line of Prior Systemic Therapyrecruiting130
2026-05 est.P1/P2Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT06241235 Study of ZG005 in Combination With Paclitaxel+Platinum-based ± Bevacizumab in Patients With Advanced Cervical CarcinomaCervical Carcinomaunknown48
2026-05 est.P2GCP-Service International West GmbHNCT06243458 RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic NeoplasmsLow Risk Myelodysplastic Syndromesactive not recruiting41
2026-05 est.P2Noorik Biopharmaceuticals AGNCT06256432 Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal SyndromeHepatorenal Syndrome; Liver Cirrhosis; Acute Kidney Injury; Ascites Hepaticactive not recruiting54
2026-05 est.P1/P2Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT06440057 Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in ParticipantNeuroendocrine Carcinomarecruiting78
2026-05 est.P2NanoEcho ABNCT06693375 To Evaluate Dose and Safety of NanoEcho Particle-1 Using NanoEcho Imaging Device Examinations of Rectal Lymph Nodes in Healthy Volunteers and Rectal Cancer PatiHealthy Volunteers; Rectal Cancer Patientsrecruiting12
2026-05 est.P2Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.NCT06798207 A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic AdvancedGynecological Tumorsrecruiting170
2026-05 est.P1/P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06829771 Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell LymphomaDiffuse Large B Cell Lymphomarecruiting90
2026-05 est.P3Beijing InnoCare Pharma Tech Co., Ltd.NCT06842199 Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque PsoriasisPlaque Psoriasis Patientsrecruiting383
2026-05 est.P3Keymed Biosciences Co.LtdNCT06956196 Study of Stapokibatrt in Children Subjects With Atopic DermatitisAtopic Dermatitisnot yet recruiting240
2026-05 est.P1/P2GC Biopharma CorpNCT06997627 A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy AdultsTetanus-diphtheria-acellular Pertussis (Tdap)recruiting120
2026-05 est.P2RDC Clinical Pty LtdNCT07028528 Levagen+ Efficacy Study on Diabetic Peripheral NeuropathyDiabetic Peripheral Neuropathyrecruiting80
2026-05 est.P1/P2Sirius Therapeutics Co., Ltd. SIRINCT07172646 A Study of SRSD216 in Patients With Elevated Lipoprotein (a)Hyperlipoproteinemia (a)recruiting84
2026-05 est.P2GI Innovation, Inc.NCT07363057 A Study to Evaluate the Effects of the Combination of GI-102 With GIB-7 on Biomarkers of Aging in Healthy Adults and Cancer SurvivorsCancer Survivors; Healthy Participant; Elderlyrecruiting15
2026-05-01 est.P1/P2GlaxoSmithKlineNCT04006808 A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney TransplantHerpes Zosterrecruiting184
2026-05-01P3Eli Lilly and Company LLYNCT05784246 A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative ColitisUlcerative Colitiscompleted63
2026-05-01 est.P1/P2AkesoNCT05951608 A Phase Ib/II Clinical Study of AK127 in Combination With AK112 in Patients With Advanced Solid TumorsAdvanced Solid Tumorsactive not recruiting216
2026-05-01 est.P3Beijing Dongfang Biotech Co., Ltd.NCT06254014 A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM PatientsType 2 Diabetes Mellitusactive not recruiting270
2026-05-01 est.P1/P2Chengdu Zenitar Biomedical Technology Co., LtdNCT06431243 A Clinical Study of Purinostat Mesylate for Injection in Patients With Advanced Solid TumorsAdvanced Solid Tumorrecruiting132
2026-05-01P2Shanghai HEP Pharmaceutical Co., Ltd.NCT06505928 A Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis DHepatitis Dcompleted90
2026-05-01P2Eli Lilly and Company LLYNCT06538116 A Study of Mevidalen (LY3154207) in Participants With Alzheimer's DiseaseAlzheimer Diseasecompleted304
2026-05-01 est.P2Bavarian NordicNCT06549530 Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the PreveMonkeypox (Mpox)active not recruiting460
2026-05-01 est.P2AkesoNCT06560112 An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian CancerRecurrent Ovarian Cancerrecruiting172
2026-05-01P2BioVie Inc. BIVINCT06757010 A Study of NE3107 in Early Parkinson'sParkinsons Disease (PD)completed57
2026-05-01 est.P2PharmaJet, Inc.NCT06919796 mRNA Covid-19 Vaccine Immune Response Comparisons Using Different Delivery RoutesEvaluate Immune Responses Following mRNA COVID-19 Vaccine Administration Through Different Delivery not yet recruiting40
2026-05-01P3BioNTech SE BNTXNCT07069309 A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher COVID-19; SARS-COV-2 Infectioncompleted774
2026-05-01P3Sanofi SNYNCT07135986 Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in ChinaMeningococcal Infection; Healthy Volunteerscompleted1602
2026-05-01 est.P3Chengdu CoenBiotech Co., LtdNCT07152639 Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and AboveTuberculosisrecruiting1784
2026-05-02P3Regeneron Pharmaceuticals REGNNCT07309432 Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen AllergyAllergic Conjunctivitisterminated24
2026-05-04P2Hoffmann-La RocheNCT05808764 A Study to Investigate the Pharmacokinetics and Safety of Risdiplam in Infants With Spinal Muscular AtrophyMuscular Atrophy, Spinalcompleted11
2026-05-04P3Neumora Therapeutics, Inc. NMRANCT06058039 Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive DisorderMajor Depressive Disordercompleted422
2026-05-04P1/P2Neuracle Science Co., LTD.NCT06249919 A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL PatientsSeneorineural Deafness; Sudden Sensorineural Hearing Losscompleted113
2026-05-04P2AstraZeneca AZNNCT06606847 A Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation in Participants With Locally Advanced Unresectable Non-Small Cell Lung Non-Small Cell Lung Canceractive not recruiting30
2026-05-05 est.P2Rocket Pharmaceuticals Inc. RCKTNCT04248439 Gene Therapy for Fanconi Anemia, Complementation Group AFanconi Anemia Complementation Group Aactive not recruiting5
2026-05-05P3KAZM Pharmaceuticals Inc.NCT06202989 Multiprofen-CC™ to Reduce Pain After Total Knee ArthroplastyPostsurgical Paincompleted306
2026-05-05P2Knoa Pharma LLCNCT06545916 Study of Sunobinop on Alcohol Consumption in Alcohol Use DisorderAlcohol Use Disordercompleted209
2026-05-06P1/P2Nerviano Medical SciencesNCT04910022 Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent GlioblastomaGlioblastoma; Diffuse Gliomaterminated80
2026-05-06P3Neumora Therapeutics, Inc. NMRANCT06058013 Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive DisorderMajor Depressive Disordercompleted430
2026-05-06P3Gilead Sciences GILDNCT06060665 Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)Primary Biliary Cholangitiscompleted96
2026-05-06P2Regeneron Pharmaceuticals REGNNCT06593600 Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)Postural Orthostatic Tachycardia Syndrome (POTS)completed82
2026-05-06P2Celldex Therapeutics CLDXNCT06727552 A Study of Barzolvolimab in Patients With Atopic DermatitisAtopic Dermatitisactive not recruiting131
2026-05-06 est.P2Longbio PharmaNCT07212426 Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.PNH - Paroxysmal Nocturnal Hemoglobinuriaactive not recruiting30
2026-05-07P3ServierNCT06780930 Phase 3 Study of Vorasidenib (S095032/AG-881) in Asian Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 orIDH2 MutationResidual or Recurrent Grade 2 IDH Mutant Gliomaactive not recruiting57
2026-05-07P3Aardvark Therapeutics, Inc. AARDNCT06828861 ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective TrialHyperphagia; Prader-Willi Syndrometerminated68
2026-05-07P2CinDome Pharma, Inc.NCT06899217 A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.Idiopathic Gastroparesiscompleted416
2026-05-07P3Laboratorios Silanes S.A. de C.V.NCT07901894 Study to Evaluate the Efficacy and Safety of Dexketoprofen / Butylscopolamine vs Dexketoprofen in Treatment of Primary DysmenorrheaPrimary Dysmenorrheacompleted130
2026-05-08P2Oneness Biotech Co., Ltd.NCT05018299 Evaluate the Efficacy and Safety of FB704A in Adult With Severe AsthmaSevere Asthmacompleted21
2026-05-08 est.P1/P2AkesoNCT05846867 A Phase Ib/II Clinical Study on AK112 Combined or Not Combined With AK119 in pMMR/MSS Colorectal CancerColorectal Canceractive not recruiting170
2026-05-08P2/P3Oneness Biotech Co., Ltd.NCT06531512 Evaluate the Efficacy and Safety of Xianglei Tangzu Gao for the Treatment of Wagner Grade II Diabetic Foot UlcersDiabetic Foot Ulceractive not recruiting120
2026-05-08P2Otsuka Pharmaceutical Development & Commercialization, Inc.NCT06637514 A Phase 2 Study of JNT-517 in Adolescent Participants With PhenylketonuriaPhenylketonuria (PKU)completed14
2026-05-09P1/P2AkesoNCT05235542 A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant TumorsAdvanced Malignant Tumorscompleted128
2026-05-10 est.P1/P2Cell Energy Life Sciences Group Co. LTDNCT06416709 Stem Cell Treatment for Lung Injury Caused by Major Infectious DiseasesLung Injuryunknown80
2026-05-11P2Incyte Corporation INCYNCT04640025 A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of ItacitinibMyelofibrosis; Postlung Transplant (Bronchiolitis Obliterans); Chronic Graft Versus Host Diseaseterminated18
2026-05-11P1/P2InxMed (Shanghai) Co., Ltd.NCT05551507 IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian CancerPlatinum-resistant Ovarian Canceractive not recruiting150
2026-05-11P2NMD Pharma A/SNCT05794139 Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular AtrophySpinal Muscular Atrophycompleted52
2026-05-11P3Novartis Pharmaceuticals NVSNCT05976243 A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamineChronic Inducible Urticariaactive not recruiting362
2026-05-11P2Ono Pharmaceutical Co., Ltd.NCT06708416 A Study of ONO-1110 in Patients With Postherpetic NeuralgiaPostherpetic Neuralgiacompleted142
2026-05-11P2AstraZeneca AZNNCT06862791 A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs AloneObesity or Overweightcompleted377
2026-05-11P2GlaxoSmithKlineNCT07121192 A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and OlderInfluenza, Humancompleted776
2026-05-12P1/P2Novartis Pharmaceuticals NVSNCT03374657 A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis PigmentosaRetinitis Pigmentosacompleted12
2026-05-12P1/P2ModernaTX, Inc.NCT05575492 A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of AgeCytomegaloviruscompleted873
2026-05-12P1/P2Pfizer PFENCT06182124 A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in AdultsPneumococcal Diseasecompleted1710
2026-05-12 est.P3Sinovac Life Sciences Co., Ltd.NCT06617715 Clinical Trial of 13-Valent Pneumococcal Conjugate VaccinePneumococcal Infectious Diseaserecruiting3080
2026-05-12P2Shanghai Juncell TherapeuticsNCT06703398 A Study of GC101 TIL in Advanced MelanomaMelanomarecruiting98
2026-05-12P2Agios Pharmaceuticals, Inc. AGIONCT06924970 A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD)Sickle Cell Diseaseactive not recruiting59
2026-05-12P2BeiGeneNCT07100938 A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid ArthritisRheumatoid Arthritisterminated49
2026-05-12P3BiocadNCT07119372 Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on DialysisAnemia; Chronic Kidney Disease; Chronic Kidney Disease Patients on Hemodialysis; Chronic Kidney Diseactive not recruiting228
2026-05-13P2Virogen Biotechnology Inc.NCT02943642 Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis FungoidesMycosis Fungoideswithdrawn
2026-05-13 est.P3CeleCor TherapeuticsNCT04825743 A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MIST-elevation Myocardial Infarction (STEMI)active not recruiting2463
2026-05-13P3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT05248646 Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)Immunoglobulin A Nephropathyactive not recruiting530
2026-05-13P2Sanofi SNYNCT05731128 A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active UlceColitis Ulcerativeactive not recruiting68
2026-05-13P3AstraZeneca AZNNCT06194825 EPIC-ATTR: A Study to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-term Safety in Chinese Subjects With Transthyretin Amyloid CardTransthyretin Amyloid Cardiomyopathyactive not recruiting64
2026-05-13P3AstraZeneca AZNNCT06465485 STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic AsthmaSevere Eosinophilic Asthmacompleted504
2026-05-13P3Eli Lilly and Company LLYNCT06921759 A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot DermatitisAtopic Hand and Foot Dermatitiscompleted221
2026-05-14P2Hoffmann-La RocheNCT05686551 GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest HHuntington Diseaseactive not recruiting301
2026-05-14P2GlaxoSmithKlineNCT06079190 Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's DiseaseAlzheimer's Diseaseterminated367
2026-05-14P2Amgen AMGNNCT06376045 A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe AsthmaAsthmaterminated317
2026-05-14P1/P2Janssen Research & Development, LLCNCT06532032 A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell Lung CancerCarcinoma, Non-Small-Cell Lungcompleted12
2026-05-14P2/P3Praxis Precision Medicines PRAXNCT06999902 Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)Focal Seizurecompleted255
2026-05-14 est.P2R-Pharm International, LLCNCT07553988 A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate CancerMetastatic Castration-resistant Prostate Canceractive not recruiting120
2026-05-15P3AstraZeneca AZNNCT03847428 Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative TreatmentHepatocellular Carcinomacompleted908
2026-05-15 est.P2AkesoNCT05382442 A Study of AK112 With or Without AK117 in Metastatic Colorectal CancerMetastatic Colorectal Canceractive not recruiting254
2026-05-15P1/P2Inflammasome TherapeuticsNCT06164587 Evaluation of Kamuvudine-8 in Subjects With Geographic AtrophyGeographic Atrophy; Age-Related Macular Degenerationcompleted30
2026-05-15P3Intra-Cellular Therapies, Inc.NCT06462612 Study of Lumateperone in the Treatment of Patients With Bipolar ManiaBipolar Disorder, Maniccompleted351
2026-05-15 est.P2Estar Medical dba Medical Technologies, LTDNCT06810726 Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Diabetic Foot Ulcer; Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus (T2DM); Neuroischemic Foot Urecruiting30
2026-05-15P3Samson Clinical Operations Pty LtdNCT06924632 Efficacy & Safety of Minoxidil SL Tablets in Men With AGAAndrogenetic Alopecia; Male Pattern Baldnesscompleted142
2026-05-15P2Genmab GMABNCT06984328 Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With Cutaneous Melanoma; Relapsed/Refractory, Locally Advanced Unresectable Melanoma (Stage IIIB, IIIC, oterminated1
2026-05-15P2Jiangsu HengRui Medicine Co., Ltd.NCT07404579 Safety and Efficacy of HRS-9190 Compared to Rocuronium for Bolus Maintenance in AdultsNeuromuscular Blockadecompleted103
2026-05-17P3Shandong Boan Biotechnology Co., LtdNCT06022861 A Study to Compare the Efficacy and Safety of LY01015 and Opdivo® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell CarEsophageal Squamous Cell Carcinomaactive not recruiting510
2026-05-18P1/P2Merck Sharp & Dohme LLC MRKNCT04305054 Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) AdvancMelanomacompleted335
2026-05-18P1/P2Xilio Development, Inc. XLONCT04896697 Vilastobart (XTX101) Monotherapy and Vilastobart and Atezolizumab Combination Therapy in Advanced Solid TumorsAdvanced Solid Tumorcompleted125
2026-05-18P2OsivaxNCT05569239 Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μgInfluenzacompleted2891
2026-05-18P3Seagen, a wholly owned subsidiary of PfizerNCT06012435 A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung CancerCarcinoma, Non-Small-Cell Lungactive not recruiting762
2026-05-18P2Shionogi Inc.NCT06017609 Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection FractionChronic Heart Failurecompleted314
2026-05-18P2Bausch & Lomb Incorporated BLCONCT07168902 Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular HypertensionGlaucomacompleted252
2026-05-19P3Hoffmann-La RocheNCT06497556 A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or MetNon-Small Cell Lung Cancer; KRAS G12C Lung Canceractive not recruiting338
2026-05-19P1/P2Genentech, Inc.NCT06850922 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Diabetic Macular Edemacompleted388
2026-05-20P2Kowa Research Institute, Inc.NCT05327127 Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver FibrosisNASHcompleted228
2026-05-20P3Definium Therapeutics US, Inc. DFTXNCT06941844 A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)Major Depressive Disorderactive not recruiting149
2026-05-20P2Instituto Grifols, S.A.NCT07264517 Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).Dry Eye Diseasecompleted103
2026-05-22P3Sanofi SNYNCT05280548 A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry DiseaseFabry Diseaseactive not recruiting104
2026-05-22P3Karyopharm Therapeutics Inc KPTIQNCT05611931 Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial CarcinomaEndometrial Canceractive not recruiting257
2026-05-22P1/P2Otsuka Beijing Research InstituteNCT06091267 PK/Efficacy Bridging Study of ASTX727 in Chinese Subjects With Myelodysplastic SyndromesMyelodysplastic Syndromesactive not recruiting72
2026-05-22P3Hoffmann-La RocheNCT06176352 A Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic MyopiaChoroidal Neovascularization Secondary to Pathologic Myopiacompleted280
2026-05-22P3Soligenix SNGXNCT06470451 Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCLCTCL/ Mycosis Fungoides; CTCL; Mycosis Fungoides; Cutaneous T Cell Lymphomaterminated70
2026-05-22P1/P2Sanofi Pasteur, a Sanofi Company SNYNCT06744205 A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and OlderInfluenza; Healthy Volunteerscompleted1162
2026-05-23P3BeOne Medicines ONCNCT04164199 Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced MalignanciesAdvanced Malignanciescompleted404
2026-05-23P2Hutchmed HCMNCT06601504 Study of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCLRelapsed/Refractory Diffuse Large B-Cell Lymphomacompleted61
2026-05-25P3Polaris Group PIINCT05712694 Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)Soft Tissue Sarcomaterminated218
2026-05-25P2ModernaTX, Inc.NCT06143046 A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated MothersRespiratory Syncytial Viruscompleted360
2026-05-25P1/P2Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. SBFMNCT06324812 Evaluation of 611 in Chinese Children and Adolescents With Moderate to Severe Atopic DermatitisDermatitis, Atopiccompleted128
2026-05-25P2Ono Pharmaceutical Co., Ltd.NCT06805565 A Study of ONO-1110 in Patients With Social Anxiety DisorderSocial Anxiety Disorder (SAD)completed115
2026-05-25P3Janssen Research & Development, LLCNCT06878404 A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic ArthritisArthritis, Psoriaticactive not recruiting552
2026-05-25 est.P3Changchun BCHT Biotechnology Co.NCT07500207 A Phase III Clinical Trial on Immunogenicity and Safety of Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell)Rabies Preventionenrolling by invitation3000
2026-05-26P3UCB Biopharma SRLNCT04009499 A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic ArthritisPsoriatic Arthritiscompleted1131
2026-05-26P1/P2Nacuity Pharmaceuticals, Inc.NCT05994534 PK and PD Study of NPI-001 and Cysteamine BitartrateCystinosiscompleted8
2026-05-26P3SeqirusNCT06087640 A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in AdultsInfluenza, Humancompleted38769
2026-05-26P2Syqe MedicalNCT06490445 A Study of Medical Cannabis Aerosol Via the Fixed-dose Syqe Inhaler as an Add-on Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)Diabetic Peripheral Neuropathic Paincompleted122
2026-05-26 est.P2JenKem Technology Co., Ltd.NCT06586866 JK-1201I in Triple Negative Breast Cancer Patients with Brain MetastasesTriple Negative Breast Cancer (TNBC); Brain Metastasasesunknown25
2026-05-26P2Pulmovant, Inc.NCT06635850 A Study of Mosliciguat in PH-ILDPulmonary Hypertension; Interstitial Lung Disease; Lung Diseases; Vascular Diseases; Cardiovascular active not recruiting135
2026-05-26P2AstraZeneca AZNNCT06851858 Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor AEndocrinology; Diabetes, Type II; Obesitycompleted69
2026-05-26 est.P2Shanghai Mabgeek Biotech.Co.LtdNCT07054034 Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma SubjectsBronchial Asthmaactive not recruiting160
2026-05-26 est.P2Circul'EggNCT07493850 Study to Assess the Efficacy of EMC-CAP-2025A on Age-Related Skin Parameters in Healthy IndividualsFacial Wrinkles; Skin Hydration; Skin Elasticityactive not recruiting60
2026-05-27P3Bristol-Myers Squibb BMYNCT03383458 A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationHepatocellular Carcinoma; Liver Canceractive not recruiting545
2026-05-27P1/P2Genenta Science SAENNCT03866109 A Study Evaluating Temferon in Patients With Glioblastoma & Unmethylated MGMTGlioblastoma Multiformeterminated25
2026-05-27P3KalVista Pharmaceuticals, Ltd.NCT05505916 An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult PaHereditary Angioedemacompleted145
2026-05-27P3KalVista Pharmaceuticals, Ltd.NCT05511922 PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 TrialHereditary Angioedemacompleted11
2026-05-27P2Microbiome Health SciencesNCT05556824 Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERDGastroesophageal Refluxcompleted255
2026-05-27P1/P2Elisigen, Inc.NCT05984927 NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular DegenerationAge-Related Macular Degenerationactive not recruiting20
2026-05-27P2ViiV HealthcareNCT05996471 A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With HuHIV Infectionsactive not recruiting185
2026-05-27P3Epion TherapeuticsNCT06100939 Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With KeratoconusKeratoconuscompleted396
2026-05-27P1/P2Lakefront Biotherapeutics NV LKFTNCT06561425 A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin LymphomaRelapsed/Refractory B-cell Non-Hodgkin Lymphoma; Lymphomas Non-Hodgkin&Amp;Amp;#39;s B-Cellterminated130
2026-05-27P2/P3Jiangsu HengRui Medicine Co., Ltd.NCT07036419 A Trial of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent PatientsOperative Sedation of Pediatric; Operative Sedation of Adolescent Patientscompleted249
2026-05-27P2NodThera Ltd. (a Rezera company)NCT07055516 Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes MellitusObesity and Type 2 Diabetescompleted176
2026-05-27P1/P2Rubedo Life Sciences, Inc.NCT07340697 Evaluate RLS-1496 Topical Cream for Actinic KeratosisActinic Keratosis (AK)active not recruiting24
2026-05-27P2Sam Chun Dang Pharm. Co. Ltd.NCT07501052 Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or DiabeticNeovascular (Wet) Age-Related Macular Degeneration; Retinal Vein Occlusion; Diabetic Macular Edema; completed33
2026-05-27P2Shenzhen Salubris Pharmaceuticals Co., Ltd.NCT07716618 A Phase II Clinical Trial of the Safety and Efficacy of SAL0120 in Patients With Chronic Kidney Disease (CKD)Chronic Kidney Diseaseactive not recruiting320
2026-05-28P3IpsenNCT06047444 A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in AdultsChronic Migraineactive not recruiting759
2026-05-28P2Gilead Sciences GILDNCT06513312 Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP)Pre-Exposure Prophylaxis of HIV Infectionactive not recruiting268
2026-05-28P3MoonLake Immunotherapeutics AG MLTXNCT06641076 Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic DrugArthritis, Psoriaticactive not recruiting960
2026-05-28P2Bausch & Lomb Incorporated BLCONCT07128628 A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye DiseaseDry Eye Diseasecompleted443
2026-05-28P3Viridian Therapeutics, Inc. VRDNNCT07155668 A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)Thyroid Eye Diseasecompleted87
2026-05-28P2BayerNCT07582328 A Study to Learn More About How Well Oxymetazoline HCl 0.05% Nasal Gel Works and How Safe It Is in Healthy AdultsNasal Congestion, Nasal Obstructioncompleted120
2026-05-29P1/P2Amgen AMGNNCT03600883 A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodKRAS p.G12C Mutant Advanced Solid Tumorscompleted713
2026-05-29P2Incyte Corporation INCYNCT04463771 Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer WhEndometrial Cancercompleted206
2026-05-29P1/P2Kyverna Therapeutics KYTXNCT05938725 KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus NephritisLupus Nephritis; Lupus Nephritis - World Health Organization (WHO) Class III; Lupus Nephritis - WHO terminated6
2026-05-29P3Shandong Suncadia Medicine Co., Ltd.NCT06589765 A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With MetforminType 2 Diabetescompleted810
2026-05-29P1/P2Be BiopharmaNCT06611436 BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia BHemophilia B; Hemophilia B, Moderately Severe or Severeterminated5
2026-05-29P2Carmot Therapeutics, Inc.NCT06628362 A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes MellitusOverweight or Obese; Type 2 Diabetes Mellitus (T2DM)completed447
2026-05-29P2Evommune, Inc. EVMNNCT06873516 Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)Chronic Spontaneous Urticariacompleted182
2026-05-30 est.P3Ganzhou Hemay Pharmaceutical Co., LtdNCT06145893 A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's DiseaseBehçet's Diseaserecruiting162
2026-05-30 est.P3Hangzhou Jiuyuan Gene Engineering Co. Ltd.,NCT06633783 A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®Obesityunknown370
2026-05-30P2Ono Pharmaceutical Co., Ltd.NCT06752590 A Clinical Study of ONO-1110 in Patients With FibromyalgiaFibromyalgiacompleted175
2026-05-30 est.P3Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT06885021 Evaluate the Safety and Efficacy of HDM1002 Tablets in Chinese Overweight and Obese AdultsOverweight and Obesitynot yet recruiting780
2026-05-31 est.P2Ascentage Pharma Group Inc. AAPGNCT04496349 A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHLT-Prolymphocytic Leukemia; Non-Hodgkins Lymphomarecruiting78
2026-05-31 est.P2US Oncology ResearchNCT04782687 Study of Selinexor Plus DRd for Newly Diagnosed Multiple MyelomaMultiple Myeloma; Myeloma Multiple; Kahler Disease; Myeloma, Plasma Cell; Myeloma-Multiple; Myelomatactive not recruiting73
2026-05-31 est.P2/P3Shanghai Pharmaceuticals Holding Co., LtdNCT05744687 Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast CancerLocally Advanced or Metastatic Breast Cancerrecruiting374
2026-05-31P2AkesoNCT05932212 AK104 for Recurrent or Metastatic Vulvar CancerVulvar Cancerterminated20
2026-05-31P3AstraZeneca AZNNCT06346392 AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction AdGastric Cancer; Gastroesophageal Junction Canceractive not recruiting594
2026-05-31 est.P1/P2Miltenyi Biomedicine GmbHNCT06347718 CAR-T Cells in Systemic B Cell Mediated Autoimmune DiseaseSystemic Lupus Erythematosus; Systemic Sclerosis; Dermatomyositis; Polymyositisrecruiting24
2026-05-31 est.P3Suzhou Suncadia Biopharmaceuticals Co., Ltd.NCT06394492 SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian CancerOvarian Cancerrecruiting440
2026-05-31 est.P2RemeGen Co., Ltd.NCT06962865 A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or RNon-Small Cell Lung Cancerrecruiting80
2026-05-31 est.P1/P2Longbio PharmaNCT07148557 A Study of Single Dose of LP-003 in Adolescent SubjectsAllergic Diseasesactive not recruiting6
2026-05-31 est.P1/P2Sinovac Biotech Co., Ltd SVANCT07400003 Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA VaccineHerpes Zoster; mRNA Vaccinerecruiting519

← 2026-04 | 2026-06 →

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.